Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 137

1.

APCR, factor V gene known and novel SNPs and adverse pregnancy outcomes in an Irish cohort of pregnant women.

Sedano-Balbás S, Lyons M, Cleary B, Murray M, Gaffney G, Maher M.

BMC Pregnancy Childbirth. 2010 Mar 10;10:11. doi: 10.1186/1471-2393-10-11.

2.

Acquired activated protein C resistance, thrombophilia and adverse pregnancy outcomes: a study performed in an Irish cohort of pregnant women.

Sedano-Balbás S, Lyons M, Cleary B, Murray M, Gaffney G, Maher M.

J Pregnancy. 2011;2011:232840. doi: 10.1155/2011/232840. Epub 2011 Aug 14.

3.

Activated protein C resistance -- in the absence of factor V Leiden -- and pregnancy.

Lindqvist PG, Svensson P, Dahlbäck B.

J Thromb Haemost. 2006 Feb;4(2):361-6.

PMID:
16420566
4.

Activated protein C resistance and factor V Leiden mutation can be associated with first-as well as second-trimester recurrent pregnancy loss.

Younis JS, Brenner B, Ohel G, Tal J, Lanir N, Ben-Ami M.

Am J Reprod Immunol. 2000 Jan;43(1):31-5.

PMID:
10698038
5.

Genetic polymorphisms on the factor V gene in women with recurrent miscarriage and acquired APCR.

Dawood F, Mountford R, Farquharson R, Quenby S.

Hum Reprod. 2007 Sep;22(9):2546-53. Epub 2007 Jul 19.

6.

Activated protein C resistance (APCR) and placental fibrin deposition.

Sedano S, Gaffney G, Mortimer G, Lyons M, Cleary B, Murray M, Maher M.

Placenta. 2008 Sep;29(9):833-7. doi: 10.1016/j.placenta.2008.06.012. Epub 2008 Aug 13.

PMID:
18703228
7.
8.

A FV multiallelic marker detects genetic components of APC resistance contributing to venous thromboembolism in FV Leiden carriers.

Mingozzi F, Legnani C, Lunghi B, Scanavini D, Castoldi E, Palareti G, Marchetti G, Bernardi F.

Thromb Haemost. 2003 Jun;89(6):983-9.

PMID:
12783110
9.
10.

Prothrombotic genotypes are not associated with pre-eclampsia and gestational hypertension: results from a large population-based study and systematic review.

Morrison ER, Miedzybrodzka ZH, Campbell DM, Haites NE, Wilson BJ, Watson MS, Greaves M, Vickers MA.

Thromb Haemost. 2002 May;87(5):779-85. Review.

PMID:
12038776
11.

[Comparison of three reactants for the detection of activated protein C resistance due to mutation of factor V Leiden during pregnancy].

Magdelaine A, Soubrier F, Berkane N, Uzan S, Verdy E.

Ann Biol Clin (Paris). 1998 Jul-Aug;56(4):445-50. French.

PMID:
9754280
12.

The predictability of factor V Leiden (FV:Q(506)) gene mutation via clotting-based diagnosis of activated protein C resistance.

Sayinalp N, Haznedaroğlu IC, Aksu S, Büyükaşik Y, Göker H, Parlak H, Ozcebe OI, Kirazli S, Dündar SV, Gürgey A.

Clin Appl Thromb Hemost. 2004 Jul;10(3):265-70.

PMID:
15247984
13.

The association of factor V leiden and prothrombin gene mutation and placenta-mediated pregnancy complications: a systematic review and meta-analysis of prospective cohort studies.

Rodger MA, Betancourt MT, Clark P, Lindqvist PG, Dizon-Townson D, Said J, Seligsohn U, Carrier M, Salomon O, Greer IA.

PLoS Med. 2010 Jun 15;7(6):e1000292. doi: 10.1371/journal.pmed.1000292. Review.

14.
15.
16.

No association between thrombosis and factor V gene polymorphisms in Chinese Han population.

Yanqing H, Fangping C, Qinzhi X, Zaifu J, Guangping W, Xiaoxia Z, Xiaoqun P, Xiaobo.

Thromb Haemost. 2003 Mar;89(3):446-51.

PMID:
12624626
17.

Risk factors for clinical manifestations in carriers of Factor V Leiden and prothrombin gene mutations.

DeSancho MT, Berlus N, Christos PJ, Rand J.

Blood Coagul Fibrinolysis. 2010 Jan;21(1):11-5. doi: 10.1097/MBC.0b013e32832d6ce7.

PMID:
19474699
18.

Prevalence of activated protein C resistance (Factor V Leiden) in Lagos, Nigeria.

Adeyemo TA, Adediran A, Akinbami AA, Akanmu AS.

Niger J Clin Pract. 2012 Apr-Jun;15(2):136-41. doi: 10.4103/1119-3077.97287.

19.

The relationship of the factor V Leiden mutation and pregnancy outcomes for mother and fetus.

Dizon-Townson D, Miller C, Sibai B, Spong CY, Thom E, Wendel G Jr, Wenstrom K, Samuels P, Cotroneo MA, Moawad A, Sorokin Y, Meis P, Miodovnik M, O'Sullivan MJ, Conway D, Wapner RJ, Gabbe SG; National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network.

Obstet Gynecol. 2005 Sep;106(3):517-24.

PMID:
16135581
20.

Resistance to activated protein C--frequent etiologic factor for venous thrombosis.

Simkova M, Simko F, Kovacs L.

Bratisl Lek Listy. 2001;102(5):240-7. Review.

PMID:
11725376
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk